InspireMD touts results of ‘one-size-fits-all’ stroke-prevention study

InspireMD’s CGuard embolic prevention stent

A clinical trial of  InspireMD’s (NYSE:NSPR) CGuard embolic prevention stent showed that it successfully treated patients whose carotid arteries varied in size, according to the company.

The investigator-initiated trial in Germany used a 10 mm diameter CGuard stent with SmartFit technology across a broad range of carotid artery diameters. Variations in diameters of the common carotid artery (CCA) and the internal carotid artery (ICA), as well as inaccurate x-ray images caused by projection angles, make choosing the correct size choice of a carotid stent challenging, according to principal investigator Christian Wissgott.

Get the full story on our sister site, Medical Design & Outsourcing.

The post InspireMD touts results of ‘one-size-fits-all’ stroke-prevention study appeared first on MassDevice.

from MassDevice http://bit.ly/2RlXMtA